These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 908868)

  • 21. The effect of protamine sulfate on the course of immune complex glomerulonephritis in the rat.
    Oite T; Shimizu F; Batsford SR; Vogt A
    Clin Exp Immunol; 1986 May; 64(2):318-22. PubMed ID: 2943540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selected markers of oxidative stress in rats with active Heymann nephritis.
    Koroliczuk A; Chibowski D; Bełtowski J; Wójcicka G
    Med Sci Monit; 2001; 7(3):369-76. PubMed ID: 11386011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced glomerular procoagulant activity and fibrin deposition in rats with mercuric chloride-induced autoimmune nephritis.
    Kanfer A; de Prost D; Guettier C; Nochy D; Le Floch V; Hinglais N; Druet P
    Lab Invest; 1987 Aug; 57(2):138-43. PubMed ID: 3475499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of rapamycin on active Heymann nephritis.
    Naumovic R; Jovovic D; Basta-Jovanovic G; Miloradovic Z; Mihailovic-Stanojevic N; Aleksic T; Jovanovic D
    Am J Nephrol; 2007; 27(4):379-89. PubMed ID: 17570905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis.
    Salvidio G; Brentjens J; Camussi G
    J Lipid Mediat; 1991; 3(2):197-204. PubMed ID: 1665716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis.
    Rahman MA; Emancipator SS; Sedor JR
    J Lab Clin Med; 1988 Nov; 112(5):619-26. PubMed ID: 2460571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive passive Heymann nephritis in the rat.
    Barabas AZ; Boyd N; Cornish J; Lannigan R
    Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of vasoactive amines in NZB-W glomerulonephritis. I. Beneficial effect of methysergide.
    Chused TM; Tarpley TM; Steinberg AD
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):281-3. PubMed ID: 4272421
    [No Abstract]   [Full Text] [Related]  

  • 32. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.
    Kniker WT; Cochrane CG
    J Exp Med; 1968 Jan; 127(1):119-36. PubMed ID: 4864670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of a new model of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2003 Dec; 84(6):245-58. PubMed ID: 14748744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of protein deficiency on the development of chronic antigen-antibody complex disease in mice.
    Reinhardt MC; Devey M; Collins M; Gregory B; Steward MW
    Clin Exp Immunol; 1981 Jun; 44(3):528-37. PubMed ID: 6459898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats.
    Egido J; Alonso F; Sanchez Crespo M; Barat A; Hernando L
    Clin Exp Immunol; 1980 Oct; 42(1):99-106. PubMed ID: 6161727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of induced humoral autoimmune response by dexamethasone in rats.
    Makker SP
    Clin Exp Immunol; 1978 Dec; 34(3):436-40. PubMed ID: 743810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heymann nephritis of rats: beneficial effect of methysergide.
    Makker SP
    J Lab Clin Med; 1977 Nov; 90(5):796-802. PubMed ID: 908868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of autologous immune complex glomerulonephritis with vasoactive amine antagonists.
    Garovoy MR; Kupor LR; Mullins JD; McPhaul JJ
    J Lab Clin Med; 1977 Oct; 90(4):638-44. PubMed ID: 143501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of experimental membranous nephropathy.
    Couser WG; Salant DJ; Adler S; Madaio MP
    Transplant Proc; 1982 Sep; 14(3):474-81. PubMed ID: 6217598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.